Vaccitech

NASDAQ: VACC · Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM

Vaccitech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
110.66M 194.38M 214.05M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
881K 976K 804K
Receivables
n/a 323K 20K
Inventory
n/a n/a n/a
Other Current Assets
15.08M 18.33M 12.69M
Total Current Assets
125.74M 213.04M 226.76M
Property-Plant & Equipment
11.76M 15.71M 9.09M
Goodwill & Intangibles
21.95M 40.48M 44.06M
Total Long-Term Assets
34.59M 57.16M 53.95M
Total Assets
160.33M 270.2M 280.71M
Account Payables
2.47M 3.75M 2.42M
Deferred Revenue
1.74M n/a 182K
Short-Term Debt
1.92M 433K 682K
Other Current Liabilities
9.53M 8.06M 7.88M
Total Current Liabilities
15.66M 12.24M 11.16M
Long-Term Debt
10.09M 8.34M 6.54M
Other Long-Term Liabilities
4.01M 2.68M 2.37M
Total Long-Term Liabilities
14.54M 14.76M 17M
Total Liabilities
30.19M 27M 28.15M
Total Debt
12.01M 8.77M 7.22M
Common Stock
1K 1K 1K
Retained Earnings
-237.66M -103.24M -108.58M
Comprehensive Income
-25.87M -33.46M -8.49M
Shareholders Equity
130.03M 242.9M 252.13M
Total Investments
n/a n/a n/a